Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Iron Supplementation in Very Preterm Infants Fed Donor Breast Milk
NCT07816601Recruiting
- Sponsor
- AdventHealth
- Start
- May 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferrous sulfate in iron deficiency anemia (IDA), sponsored by AdventHealth. Primary endpoints: Serum ferritin level at 28 days and Hematocrit level at 28 days. Started May 2026; status: recruiting.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07816601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816601.